Latest Breaking News On - மனிதன் மருந்துகள் ஒழுங்குமுறைகள் - Page 5 : comparemela.com

'A massive step forward': Everything the government has said about the Oxford/AstraZeneca Covid-19 vaccine approval

A massive step forward : Everything the government has said about the Oxford/AstraZeneca Covid-19 vaccine approval The Health Secretary, Matt Hancock, said it was a massive step forward Coronavirus LIVE updates as widespread Boxing Day lockdown looms (Image: Getty Images) Sign up for the latest from M.E.N. political editor Jennifer WilliamsInvalid EmailSomething went wrong, please try again later. Subscribe When you subscribe we will use the information you provide to send you these newsletters. Sometimes they’ll include recommendations for other related newsletters or services we offer. OurPrivacy Noticeexplains more about how we use your data, and your rights. You can unsubscribe at any time.

EU guidance documents referred to in the Human Medicines Regulations 2012

EU guidance documents referred to in the Human Medicines Regulations 2012 Links to EU guidance, as it stood immediately before end of transition period. From: Contents This is EU guidance specifically referred to in the Human Medicines Regulations 2012 ( HMRs), as these are due to be amended by the Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 and the Human Medicines (Amendment etc.) (EU Exit) Regulations 2020. Before the end of the transition period, the Government is putting in place legislation to allow the continued sale of and access to medicines as well as to implement the Northern Ireland Protocol in relation to medicines regulation.

Guidance on handling of Decentralised and Mutual Recognition Procedures approved or pending on 1 January 2021

The approach the MHRA intends to take for products approved or pending in decentralised procedure (DCP) or mutual recognition procedures (MRP).

CIRD210170 - Corporate Intangibles Research and Development Manual - HMRC internal manual

CIRD210170 - Patent Box: qualifying companies: qualifying IP rights: other rights to which Part 8A applies - Supplementary Protection Certificates and Marketing Authorisations You should check the other guidance available on GOV.UK from HMRC as Brexit updates to those pages are being prioritised before manuals. The scope of the Patent Box extends to rights similar to patents which relate to human and veterinary medicines, plant breeding and plant varieties. It is not the intention to limit the scope of the Patent Box as a result of the UK’s exit from the EU, so UK equivalent rights have been included from 1 January 2021 (see CTA/357BB), in addition to rights under EU law, which continue to qualify (see CTA/357BBA).

Everything you need to know about the UK's COVID-19 vaccination programme